|
Peptide peak intensities increased or decreased by the treatment of granulocyte-macrophage colony-stimulating factor (GM-CSF) |
||
| m/z |
Ratio (treated/untreated) |
Fraction |
|
|
||
| 2,176.0 |
5.0 |
Cytosol |
| 2,216.0 |
3.3 |
Cytosol |
| 763.4 |
3.1 |
Cytosol |
| 2,042.1 |
2.9 |
Cytosol |
| 963.5 |
2.9 |
Cytosol |
| 2,726.4 |
2.8 |
Cytosol |
| 2,008.9 |
2.8 |
Cytosol |
| 2,138.2 |
2.7 |
Cytosol |
| 1,882.9 |
2.7 |
Cytosol |
| 854.4 |
2.7 |
Cytosol |
| 795.5 |
2.7 |
Cytosol |
| 1,515.7 |
2.6 |
Cytosol |
| 1,883.9 |
2.6 |
Cytosol |
| 1,630.8 |
2.5 |
Cytosol |
| 825.2 |
7.8 |
Organelle/membrane |
| 1,791.0 |
4.0 |
Organelle/membrane |
| 841.2 |
3.7 |
Organelle/membrane |
| 2,191.3 |
3.7 |
Organelle/membrane |
| 845.2 |
3.0 |
Organelle/membrane |
| 2,690.6 |
2.9 |
Organelle/membrane |
| 861.2 |
2.8 |
Organelle/membrane |
| 2,045.2 |
2.7 |
Organelle/membrane |
| 1,954.2 |
2.7 |
Organelle/membrane |
| 1,813.0 |
2.6 |
Organelle/membrane |
| 711.4 |
2.6 |
Organelle/membrane |
| 1,479.9 |
2.5 |
Organelle/membrane |
| 2,384.2 |
2.5 |
Organelle/membrane |
| 841.1 |
2.6 |
Nuclei |
| 792.5 |
0.3 |
Nuclei |
| 1,577.9 |
2.9 |
Cytoskeleton |
| 1,562.0 |
2.8 |
Cytoskeleton |
| 1,569.9 |
2.6 |
Cytoskeleton |
| 1,584.0 |
2.6 |
Cytoskeleton |
| 1,231.8 |
2.6 |
Cytoskeleton |
| 1,810.0 |
0.4 |
Cytoskeleton |
| 2,064.1 |
0.4 |
Cytoskeleton |
| 743.1 |
0.4 |
Cytoskeleton |
| 2,053.1 |
0.4 |
Cytoskeleton |
| 2,036.1 |
0.4 |
Cytoskeleton |
| 1,750.0 |
0.3 |
Cytoskeleton |
| 1,536.0 |
0.3 |
Cytoskeleton |
| 2,621.4 |
0.3 |
Cytoskeleton |
| 1,772.3 |
0.3 |
Cytoskeleton |
| 1,762.0 |
0.3 |
Cytoskeleton |
| 2,152.2 |
0.3 |
Cytoskeleton |
| 2,035.1 |
0.3 |
Cytoskeleton |
| 2,015.2 |
0.3 |
Cytoskeleton |
Katano et al. Arthritis Research & Therapy 2009 11:R3 doi:10.1186/ar2587 |
||